Grow Therapy equips licensed clinicians with scheduling, billing, EHR software, and AI-assisted documentation tools that have cut note-taking time by nearly 70% while exceeding manual accuracy. More than two million people have used the platform, accumulating 10 million therapy and medication-management appointments, including seven million visits in 2025 alone. The company works with 125+ insurance carriers, giving 220 million Americans in-network access and keeping the average out-of-pocket cost at $21 per visit, with one-third paying nothing. Client satisfaction is high, evidenced by an 85 Net Promoter Score and internal data showing 80% of clients experience measurable symptom improvement within 30 days. Grow’s mobile app extends clinically guided AI support between sessions, and outcome-tracking tools feed insights back to providers. Looking ahead, the company plans to deepen integrations with employers, health plans, and health systems to create a seamless care pathway. Grow Therapy has raised $328 million to date, funding continued product innovation and expansion of its care network.

Total raised

$328M

Funding rounds

4

Latest round

Series D

Latest activity

Mar 2026